This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
How has treatment for tricuspid valve disease evolved? Makkar: For decades, tricuspid regurgitation was largely overlooked, often addressed only during surgeries for other heartvalves. In such cases, TTVR, which replaces the valve entirely, may be a better option. How do you discuss options with patients?
Food and Drug Administration (FDA) approval of its TriClip, a first-of-its-kind device to repair leaky tricuspid heartvalve, for which more than 1.6 are affected by tricuspid regurgitation, 1 which can severely impact quality of life. Abbott has announced U.S million people in the U.S. are estimated to be affected.
Patients had a valve annulus of 430 mm2 or less and anatomy suitable for either the Evolut PRO/PRO+/FX or the SAPIEN 3/3 Ultra. The other half of participants received the balloon-expandable SAPIEN valve, which is made from bovine tissue and inserted inside the heartvalve by using a balloon to expand to full size.
How has treatment for tricuspid valve disease evolved? Makkar: For decades, tricuspid regurgitation was largely overlooked, often addressed only during surgeries for other heartvalves. In such cases, TTVR, which replaces the valve entirely, may be a better option. How do you discuss options with patients?
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Anatomy 
52 
Let's personalize your content